Event chart EUROFINS SCIENTIFIC SE |
|
|
Upcoming events on EUROFINS SCIENTIFIC SE |
|
06/16/22 | | Exane BNPP CEO Conference |
07/27/22 | | Interim 2022 Earnings Release |
07/27/22 | 09:00am | | Interim 2022 Earnings Call |
03/07/23 | | FY 2022 Earnings Release (Projected) |
08/31/23 | | Interim 2023 Earnings Release (Projected) |
03/05/24 | | FY 2023 Earnings Release (Projected) |
08/29/24 | | Interim 2024 Earnings Release (Projected) |
|
Past events on EUROFINS SCIENTIFIC SE |
|
05/11/22 | | Societe Generale European ESG/SRI Conference |
05/10/22 | | Berenberg Diagnostics Conference |
04/26/22 | 10:30am | | Annual General Meeting |
04/21/22 | 09:00am | | Q1 2022 Sales and Revenue Call - Interim Management Statement |
04/21/22 | 01:15am | | Q1 2022 Sales and Revenue Release - Interim Management Statement |
02/22/22 | 09:00am | | FY 2021 Earnings Call |
02/22/22 | 01:15am | | FY 2021 Earnings Release |
12/06/21 | | Berenberg European Conference |
10/21/21 | 09:00am | | Q3 2021 Sales and Revenue Call - Interim Management Statement |
10/21/21 | 01:15am | | Q3 2021 Sales and Revenue Release - Interim Management Statement |
|
Past dividends on EUROFINS SCIENTIFIC SE |
|
07/01/21 | | Annual 0.68 EUR |
07/03/19 | | Annual 2.88 EUR |
06/28/18 | | Annual 2.4 EUR |
06/29/17 | | Annual 2 EUR |
06/29/16 | | Annual 1.45 EUR |
06/29/15 | | 1.32 eur |
06/27/14 | | Annual 1.2 EUR |
07/05/13 | | Annual 1 EUR |
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M € |
Released Forecast Spread | 2 971 2 965 0,22% | 3 781 3 797 -0,41% | 4 563 4 527 0,79% | 5 439 5 418 0,38% | 6 718 6 572 2,2% | 6 591 |
Operating income (EBITDA) M € |
Released Forecast Spread | 557 544 2,4% | 720 702 2,6% | 931 898 3,6% | 1 413 1 293 9,2% | 1 902 1 870 1,7% | 1 587 |
Operating profit (EBIT) M € |
Released Forecast Spread | 400 373 7,1% | 521 482 8,0% | 574 550 4,3% | 1 024 803 27% | 1 473 1 386 6,3% | 1 081 |
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | 250 288 -13% | 290 356 -19% | 272 303 -10% | 694 595 17% | 1 057 1 082 -2,4% | 889 |
Net income M € |
Released Forecast Spread | 217 213 1,7% | 224 266 -16% | 195 269 -28% | 539 425 27% | 783 797 -1,8% | 670 |
EPS € |
Released Forecast Spread | 1,27 1,21 4,6% | 1,27 1,51 -16% | 1,05 1,66 -37% | 2,75 2,20 25% | 3,91 4,00 -2,2% | 3,31 | Announcement Date | 03/06/2018 | 03/05/2019 | 03/04/2020 | 03/01/2021 | 02/22/2022 | - |
|
|
Fiscal Period : December | 2017 S2 | 2018 S1 | 2018 S2 | 2019 S1 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 | 2020 Q4 | 2020 S2 | 2021 Q1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
Sales M € |
Released Forecast Spread | 1 575 1 592 -1,1% | 1 743 1 725 1,1% | 2 038 2 127 -4,2% | 2 168 2 100 3,2% | 1 228 1 218 0,86% | 2 395 2 380 0,63% | 1 142 1 055 8,2% | 1 181 1 180 0,13% | 2 323 2 325 -0,07% | 1 413 1 319 7,1% | 1 703 1 671 1,9% | 3 116 3 106 0,33% | 1 614 1 542 4,7% | 1 658 1 525 8,8% | 3 272 3 186 2,7% | 1 630 1 590 2,5% | 1 816 1 800 0,89% | 3 446 3 348 2,9% | 1 760 1 697 3,7% | 3 367 | 3 390 | 3 510 | 3 423 |
Operating income (EBITDA) M € |
Released Forecast Spread |
| 320 321 -0,19% | 399
| 415 337 23% |
| 516 524 -1,6% |
|
| 493 449 9,8% |
|
| 920 817 13% |
|
| 1 008 821 23% |
|
| 894 852 4,9% |
| 816 |
|
|
|
Operating profit (EBIT) M € |
Released Forecast Spread |
| 227 222 2,1% |
| 251 241 4,3% |
| 323 337 -4,2% |
|
| 311 250 24% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Announcement Date | 03/06/2018 | 07/31/2018 | 03/05/2019 | 08/29/2019 | 03/04/2020 | 03/04/2020 | 04/28/2020 | 08/06/2020 | 08/06/2020 | 10/22/2020 | 03/01/2021 | 03/01/2021 | 04/28/2021 | 08/05/2021 | 08/05/2021 | 10/21/2021 | 02/22/2022 | 02/22/2022 | 04/21/2022 | - | - | - | - | |
|
|
Upcoming sector events for EUROFINS SCIENTIFIC SE |
|
|
|
Past sector events for EUROFINS SCIENTIFIC SE |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
|